Philip E Silkoff, MD
Acting Chief Medical Officer, Pulmonologist

THIRD POLE THERAPEUTICS, JANSSEN R&D, ASTRAZENECA, NATIONAL JEWISH HEALTH DENVER

A pulmonologist and senior clinical trial physician executive with more than twenty years of experience in the pharmaceutical and medical device industry across all phases of drug and medical device programs. Phil previously held the positions of Senior Medical Director at Janssen R&D and Medical Director at AstraZeneca. Phil has overseen multiple clinical studies in asthma, COPD, interstitial pulmonary fibrosis and sarcoidosis.  Dr. Silkoff’s industry career was preceded by a long and successful academic career including appointment as Associate Professor at the University of Colorado, published intellectual property, and multiple peer-reviewed articles and book chapters in the field of pulmonary medicine. Areas of focus include early and late-stage clinical development, regulatory strategy and tactics including FDA interactions, discovery and preclinical and assistance in the business strategy and assessment of market opportunities. Dr. Silkoff holds an MBBS in Respiratory Medicine from University College London and an MBBS in Medicine from the University of London.